11 Jul PRDX1 controls nuclear ROS scavenging and aspartate availability.
A new study co-led by Savvas Kourtis from our lab and Amandine Moretton from Joanna Loizou's lab at the CeMM, Vienna reveals that in response to DNA damage, such as from chemotherapy drugs, the nucleus of a cell activates antioxidant enzymes to protect itself. We...
